Biochemical control of acromegaly in noncured patients is usually defined as serum growth hormone (GH) levels <2.0 µg/l, plus normal-for-age serum levels of insulin-like growth factor I (IGF-I).

The various surgical and radiologic methods of treating acromegaly have dramatically improved over the past 75 years. In addition to the improvements in primary surgical and radiation methods ...